FDA Declines Rush Request for Alzheimer’s Drug Donanemab
According to drugmaker Eli Lilly, the FDA has rejected the company’s application for the FDA’s “Accelerated Approval” designation for experimental Alzheimer’s drug donanemab. The…
According to drugmaker Eli Lilly, the FDA has rejected the company’s application for the FDA’s “Accelerated Approval” designation for experimental Alzheimer’s drug donanemab. The…
When Wendy Nelson, Ph.D., discovered that she carries two copies of Alzheimer’s genetic biomarker ApoE4, a gene variant associated with heightened Alzheimer’s risk, she…
I first saw the briefcase-sized computer monitor at the Alzheimer’s Association’s conference last summer in San Diego. Tom O’Neill, the president of a company…
Could getting serious about exercise really have a substantial impact on cognition as we age? Determining exactly how often someone needs to work out…
Gordon Van Slyke’s mother and sister both passed away of early onset Alzheimer’s when they were in their early 60s. When he decided to…
Memory loss, confusion, cognitive impairment, and brain inflammation. Those aren’t just the signs and symptoms of Alzheimer’s disease and dementia. A year after a…
At Being Patient, we host regular LiveTalks with experts, advocates and people living with Alzheimer’s and dementia as a part of our mission to…
Professor Lili Liu and postdoctoral fellow Hector Perez at the University of Waterloo School of Public Health Sciences discuss how to prevent missing person…
UPDATE: 3 March 2024, 8:16 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Update: As of July 6, 2023, the drug has full, traditional FDA approval. Today, the Food and Drug Administration approved Leqembi (generic name lecanemab), a…
An Offer He Couldn’t Refuse: Reporter Phil Gutis interviews Joanne Pike on her first day as CEO of the Alzheimer’s Association As any reporter…
Drugmakers Eisai and Biogen took their anti-amyloid Alzheimer’s treatment, lecanemab, to the finish line. By clearing amyloid plaques in the brains of people with…
University of Birmingham neurology fellow and dreams researcher Abidemi Otaiku discusses his new findings that people with Parkinson’s disease have nightmares as much as…
Almost 400,000 Australians are living with dementia. A million or more family members and friends care for and support them. About two-thirds of people…
The connections between the neurons in your brain enable you to do amazing things, from brushing your teeth to solving calculus equations. When these…